(Q35165338)

6 August 2017

title

Antagonists in poor-responder patients (English)

1 reference

6 August 2017

Alan B Copperman

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

6 August 2017

published in

Fertility and Sterility

1 reference

6 August 2017

volume

80 Suppl 1

1 reference

6 August 2017

page(s)

S16-24; discussion S32-4

1 reference

The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Ovarian reserve test with the gonadotrophin-releasing hormone agonist buserelin: correlation with in-vitro fertilization outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Treatment of low responders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Ovarian volume: a novel outcome predictor for assisted reproduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Predictors of IVF outcome by three-dimensional ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Three years of in vitro fertilization at Norfolk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

Gonadotropin-releasing hormone antagonists implications for oocyte quality and uterine receptivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

GnRH antagonist in assisted reproduction: a Cochrane review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900765-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(03)00765-9

1 reference

release_icxmmiyosjcpnlt4idp2uxiu4m

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/icxmmiyosjcpnlt4idp2uxiu4m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference